INIS
evaluation
100%
in vitro
100%
in vivo
100%
cancer
100%
breasts
100%
delivery
100%
liposomes
100%
drugs
22%
toxicity
11%
comparative evaluations
11%
mice
11%
tumors
11%
distribution
11%
surfaces
11%
nanoparticles
11%
particle size
11%
design
11%
morphology
11%
retention
11%
scanning electron microscopy
11%
monoclonal antibodies
11%
uptake
11%
blood circulation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
100%
Liposome
100%
Small Interfering RNA
100%
Paclitaxel
100%
Trastuzumab
100%
Mouse Model
11%
Scanning Electron Microscopy
11%
Nude Mouse
11%
Zeta Potential
11%
Antiinfective Agent
11%
Nanoparticle
11%
Neoplasm
11%
Combination Therapy
11%
Monoclonal Antibody
11%
Biochemistry, Genetics and Molecular Biology
Small Interfering RNA
100%
Trastuzumab
100%
Mouse Model
16%
Scanning Electron Microscopy
16%
Anticancer
16%
In Vitro Release
16%
Cancer Cell
16%
Circulation
16%
Nude Mouse
16%
Zeta Potential
16%
Drug Retention
16%
Monoclonal Antibody
16%